Erdheim-chester disease

Current Opinion in Rheumatology

Volumn 24, Issue 1, 2012, Pages 53-59

  Haroche, Julien ^a,b,d   Arnaud, Laurent ^a,c   Amoura, Zahir ^a,b,c  

^a Pitié Salpêtrié Re Hospital   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UMR S 945 INSERM UPMC   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cytokine; Erdheim Chester disease; Histiocytosis; Interferon alpha; Langerhans cell histiocytosis

Indexed keywords

ALPHA INTERFERON; CD68 ANTIGEN; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PEGINTERFERON; T6 ANTIGEN; TECHNETIUM 99M;

BONE PAIN; BONE SCINTISCANNING; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DRUG EFFICACY; ENDOCRINE DISEASE; ERDHEIM CHESTER DISEASE; EYE DISEASE; HEART DISEASE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; LUNG DISEASE; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; SKIN DISEASE; SURVIVAL RATE; TH1 CELL; URINARY TRACT DISEASE;

ERDHEIM-CHESTER DISEASE; HUMANS; INTERFERON-ALPHA; PROGNOSIS;

EID: 82955227496     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32834d861d     Document Type: Review

References (45)

1. Chester W. Über Lipoidgranulomatose. Virchows Arch Pathol Anat 1930; 279:561-602.
2. Adam Z, Koukalova R, Sprlakova A, et al. Successful treatment of Erdheim- Chester disease by 2-chlorodeoxyadenosine-based chemotherapy: Two case studies and a literature review. Vnitr Lek 2011; 57:576-589.
3. Arnaud L, Hervier B, Neel A, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: A multicenter survival analysis of 53 patients. Blood 2011; 117:2778-2782.
4. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: Report of 6 new cases and a literature review. Medicine (Baltimore) 2004; 83:371-392. (Pubitemid 39541113)
5. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease: Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996; 75:157-169. (Pubitemid 26159212)
6. Balink H, Hemmelder MH, de Graaf W, et al. Scintigraphic diagnosis of Erdheim-Chester disease. J Clin Oncol 2011; 29:e470-e472.
7. Haroche J, Amoura Z, Wechsler B, et al. Erdheim-Chester disease. Presse Med 2007; 36:1663-1668. (Pubitemid 47595440)
8. Andre M, Delevaux I, de Fraissinette B, et al. Two enlarged kidneys: A manifestation of Erdheim-Chester disease. Am J Nephrol 2001; 21:315-317.
9. Dion E, Graef C, Haroche J, et al. Imaging of thoracoabdominal involvement in Erdheim-Chester disease. AJR Am J Roentgenol 2004; 183:1253-1260. (Pubitemid 44210586)
10. Haroche J, Amoura Z, Trad SG, et al. Variability in the efficacy of interferonalpha in Erdheim-Chester disease by patient and site of involvement: Results in eight patients. Arthritis Rheum 2006; 54:3330-3336. (Pubitemid 44622105)
11. Brower AC, Worsham GF, Dudley AH. Erdheim-Chester disease: A distinct lipoidosis or part of the spectrum of histiocytosis? Radiology 1984; 151:35-38. (Pubitemid 14165346)
12. Tsai JW, Tsou JH, Hung LY, et al. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: A rare case with human androgen-receptor gene analysis. J Am Acad Dermatol 2010; 63:284-291.
13. Wang KH, Cheng CJ, Hu CH, et al. Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai-Dorfman disease. Br J Dermatol 2002; 147:770-774.
14. Jeon IS, Lee SS, Lee MK. Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease. Pediatr Blood Cancer 2010; 55:745-747.
15. Tran TA, Fabre M, Pariente D, et al. Erdheim-Chester disease in childhood: A challenging diagnosis and treatment. J Pediatr Hematol Oncol 2009; 31:782-786.
16. 18F- fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum 2009; 60:3128-3138.
17. Stenova E, Steno B, Povinec P, et al. FDG-PET in the Erdheim-Chester disease: Its diagnostic and follow-up role. Rheumatol Int 2010. [Epub ahead of print] An interesting illustration of the usefulness of PET scan for assessing the activity and the extent of the disease in this case report with multisystemic involvement.
18. Dion E, Graef C, Miquel A, et al. Bone involvement in Erdheim-Chester disease: Imaging findings including periostitis and partial epiphyseal involvement. Radiology 2006; 238:632-639. (Pubitemid 43134376)
19. Serratrice J, Granel B, De Roux C, et al. 'Coated aorta': A new sign of Erdheim-Chester disease. J Rheumatol 2000; 27:1550-1553. (Pubitemid 30354063)
20. Gupta A, Kelly B, McGuigan JE. Erdheim-Chester disease with prominent pericardial involvement: Clinical, radiologic, and histologic findings. Am J Med Sci 2002; 324:96-100. (Pubitemid 34851732)
21. Haroche J, Cluzel P, Toledano D, et al. Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: Magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients. Circulation 2009; 119:e597-e598.
22. Fink MG, Levinson DJ, Brown NL, et al. Erdheim-Chester disease: Case report with autopsy findings. Arch Pathol Lab Med 1991; 115:619-623.
23. Loeffler AG, Memoli VA. Myocardial involvement in Erdheim-Chester disease. Arch Pathol Lab Med 2004; 128:682-685. (Pubitemid 41490431)
24. Kenn W, Stabler A, Zachoval R, et al. Erdheim-Chester disease: A case report and literature overview. Eur Radiol 1999; 9:153-158.
25. Alper MG, Zimmerman LE, Piana FG. Orbital manifestations of Erdheim- Chester disease. Trans Am Ophthalmol Soc 1983; 81:64-85. (Pubitemid 14111588)
26. Sheidow TG, Nicolle DA, Heathcote JG. Erdheim-Chester disease: Two cases of orbital involvement. Eye (Lond) 2000; 14 (Pt 4):606-612.
27. Khamseh ME, Mollanai S, Hashemi F, et al. Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002; 25:727-729.
28. Tritos NA, Weinrib S, Kaye TB. Endocrine manifestations of Erdheim- Chester disease (a distinct form of histiocytosis). J Intern Med 1998; 244:529-535. (Pubitemid 28552860)
29. Haroche J, Amoura Z, Touraine P, et al. Bilateral adrenal infiltration in Erdheim-Chester disease: Report of seven cases and literature review. J Clin Endocrinol Metab 2007; 92:2007-2012. (Pubitemid 46997091)
30. Opie KM, Kaye J, Vinciullo C. Erdheim-Chester disease. Australas J Dermatol 2003; 44:194-198. (Pubitemid 36960444)
31. Droupy S, Attias D, Eschwege P, et al. Bilateral hydronephrosis in a patient with Erdheim-Chester disease. J Urol 1999; 162:2084-2085.
32. Arnaud L, Pierre I, Beigelman-Aubry C, et al. Pulmonary involvement in Erdheim-Chester disease: A single-center study of thirty-four patients and a review of the literature. Arthritis Rheum 2010; 62:3504-3512.
33. Brun AL, Touitou-Gottenberg D, Haroche J, et al. Erdheim-Chester disease: CT findings of thoracic involvement. Eur Radiol 2010; 20:2579-2587.
34. Lachenal F, Cotton F, Desmurs-Clavel H, et al. Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: Report of 6 cases and systematic review of the literature. J Neurol 2006; 253:1267-1277. (Pubitemid 44691550)
35. Drier A, Haroche J, Savatovsky J, et al. Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 2010; 255:586-594.
36. Myra C, Sloper L, Tighe PJ, et al. Treatment of Erdheim-Chester disease with cladribine: A rational approach. Br J Ophthalmol 2004; 88:844-847. (Pubitemid 38725610)
37. Boissel N, Wechsler B, Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001; 135:844-845. (Pubitemid 33051276)
38. Gaspar N, Boudou P, Haroche J, et al. High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement. Haematologica 2006; 91:1121-1125. (Pubitemid 44204782)
39. Braiteh F, Boxrud C, Esmaeli B, et al. Successful treatment of Erdheim- Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood 2005; 106:2992-2994.
40. Janku F, Amin HM, Yang D, et al. Response of histiocytoses to imatinib mesylate: Fire to ashes. J Clin Oncol 2010; 28:e633-e636. An interesting therapeutic trial regarding the efficacy of imatinib mesylate in histiocytoses, two patients with LCH and one with ECD with CNS involvement.
41. Haroche J, Amoura Z, Charlotte F, et al. Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. Blood 2008; 111:5413-5415.
42. Aouba A, Georgin-Lavialle S, Pagnoux C, et al. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010; 116: 4070-4076.
43. Stoppacciaro A, Ferrarini M, Salmaggi C, et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim- Chester disease: Implications for pathogenesis. Arthritis Rheum 2006; 54:4018-4022. (Pubitemid 44955906)
44. Dagna L, Girlanda S, Langheim S, et al. Erdheim-Chester disease: Report on a case and new insights on its immunopathogenesis. Rheumatology (Oxford) 2010; 49:1203-1206.
45. Arnaud L, Gorochov G, Charlotte F, et al. Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: A single-center series of 37 patients. Blood 2011; 117:2783-2790.